Piper Sandler Reiterates Overweight on Inspire Medical Systems (INSP) as 'P&L Leverage Shines Again'

February 11, 2025 6:52 AM

Piper Sandler analyst Adam Maeder reiterated an Overweight rating and $233.00 price target on Inspire Medical Systems (NYSE: INSP).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found